Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Results showed that GLP-1 receptor agonists and SGLT2 inhibitors were superior in reducing the risk of MACE when compared to DPP-4 inhibitors (HR 086 [082089] and 086 [082090], respectively), but no difference was found between SGLT2 inhibitors and GLP-1 receptor agonists in reducing rate of MACE (HR of 101 (094107)) (68)
Ziihera is a bispecific antibody that targets two non-overlapping sites on the HER2 receptor
Theriogenology 145:100108
together with the COA, they create a stronger analytical record
J.RennenbergH.FoyerC
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
